New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
FDA Approval of New COVID-19 Boosters Could Come by Friday
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
Moderna Says Updated COVID-19 Vaccine Shields Against Highly Mutated New Variant
Scientists found the variant appears to be less concerning than initially thought, with data showing it is 60 percent less infectious than XBB.1.5 variants
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines
Teens May Have Missed Vaccinations During COVID-19 Pandemic
Among adolescents born in 2008, vaccination coverage by age 14 years continued to lag versus earlier birth cohorts
Updated COVID-19 Vaccines Will Roll Out Mid-September, Officials Say
The new vaccines will target the XBB.1.5 coronavirus subvariant and offer some protection for closely related strains
Better Responses Seen With Booster mRNA COVID-19 Vaccine in Pregnancy
Robust immune responses found after booster dose; efficient transplacental antibody transfer was seen
Moderna COVID-19 Vaccine Tied to Lower Adverse Event Risk in Older Adults
mRNA-1273 vaccine also tied to greater protection against COVID-19 in older adults
CDC Panel Backs RSV Vaccine for Seniors
Panel called for ‘shared clinical decision-making’ between doctors and patients, stopped short of recommending that all seniors get the shots
FDA Advisers Say Next Round of COVID-19 Booster Shots Should Target an XBB Variant
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.